ArticleNature communications2022

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.

Maryam A Y Al-Nesf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.